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012.07.0Abstract Introduction and aim: Sepsis is deﬁned as the systemic inﬂammatory response syndrome
(SIRS) which occurs during infection. One of the important features of sepsis is myocardial dysfunc-
tion. We designed this study to investigate the cardiac systolic and diastolic functions in patients pre-
senting with SIRS and septic shock.
Subjects and methods: Between July 2009 and August 2010, 40 patients diagnosed with systemic sep-
sis who were admitted to the Cardiac Care Unit of Mansoura Medicine Specialized Hospital were
enrolled in this study. Patients were divided into 2 groups: SIRS group composed of 18 patients
(13 males); and Septic shock group composed of 22 patients (11 males).
Results: Indices of systolic function were signiﬁcantly impaired in septic shock patients, where sig-
niﬁcantly higher left ventricular systolic (LVESD) and diastolic (LVEDD) dimensions and lower
ejection fraction (EF) existed in these patients compared with SIRS group. Similar to the systolic
function, the indices of diastolic function were also deranged in septic shock patients; who had sig-
niﬁcantly shorter mean isovolumetric relaxation time and deceleration time than SIRS patients; indi-
cating the high prevalence of type 2 (pseudonormal) diastolic dysfunction in patients with septic
shock compared to the milder type 1 diastolic dysfunction (impaired relaxation pattern) which pre-
dominated in SIRS patients.
Conclusion: LVESD and LVEDD are signiﬁcantly increased in septic shock patients compared to
patients with SIRS; while EF shows the reverse. Patients with SIRS showed mild diastolic dysfunc-
tion while severe form of diastolic dysfunction has been found in patients with septic shock.
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021. Introduction
Sepsis, deﬁned as ‘‘the systemic inﬂammatory response syn-
drome (SIRS) which occurs during infection’’1, is generally
viewed as a disease aggravated by the inappropriate immune
response encountered in the affected individuals.1,2 Although
much has been learned about the pathophysiology of sepsis
in the last decade, the mortality of this condition is still ele-
vated; especially with the grave condition known as ‘‘septic
shock’’.1 One of the most important features of sepsis is myo-
cardial dysfunction.4 In fact, the cardiovascular system and itsg by Elsevier B.V. All rights reserved.
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sic research for more than 5 decades. Waisbren, the ﬁrst to de-
scribe cardiovascular dysfunction due to sepsis, recognized a
hyperdynamic state with full bounding pulse, ﬂushing, fever,
oliguria, and hypotension.5 He also described another category
of patients who were clammy, pale, and hypotensive with low
volume pulse who appeared more severely ill. With hindsight,
the latter group might have undergone volume under-resusci-
tation; and indeed timely and adequate volume therapy has
been demonstrated to be one of the most effective supportive
measures in treating sepsis.6,7 Under the conditions of ade-
quate volume resuscitation, the profoundly reduced systemic
vascular resistance encountered in sepsis leads to a concomi-
tant elevation in cardiac index which obscures the ongoing
myocardial dysfunction.7 However, signiﬁcant reductions in
both stroke volume and ejection fraction (EF) in septic pa-
tients were observed despite normal total cardiac output.4,8
Importantly, the presence of cardiac dysfunction in sepsis
has been associated with a very high mortality rate of 70%
to 90% compared with 20% in septic patients without cardio-
vascular impairment.4 Considering the observation of Wais-
bren5, we designed this study to investigate the cardiac
systolic and diastolic functions in patients presenting with
SIRS and septic shock; in addition to studying the mortality
pattern of these patients.
1.1. Patients and methods
Between July 2009 and August 2010, forty patients diagnosed
with various degrees of systemic sepsis who were admitted to
theCardiac Care Unit (CCU) ofMansouraMedicine Specialized
Hospital were enrolled in this study. Inclusion criteria included
hypotension (deﬁned as a systolic arterial blood pressure
<90 mmHg or reduction from baseline by >40 mmHg) with
(SIRS group) or without (septic shock group) response to ﬂuids
resuscitation; in addition to 2 or more of the following:
– Temperature > 38 C or <36 C,
– Heart rate (HR) > 90 bpm,
– Respiratory rate (RR) > 30/min with PaCO2 <32,
– Total leukocytic count (TLC) > 12 · 109/L or <4 · 109/L
or >10% staff cells.
Patients were divided into 2 groups according to the ACCP/
SCCM (College of Chest Physicians/Society of Critical Care
Medicine) Consensus Conference Committee of sepsis):
1.1.1. SIRS (survivor) group
Composed of 18 patients (13 males) with systemic inﬂamma-
tory response and severe sepsis, 14 of them survived until hos-
pital discharge.
1.1.2. Septic shock group
Composed of 22 patients (11 males) with septic shock, which is
deﬁned as1 sepsis-induced hypotension despite adequate ﬂuid
resuscitation along with the presence of perfusion abnormali-
ties such as oliguria, lactic acidosis, and acute alteration in
mental state. Out of these patients, 18 died within 3 weeks of
hospital admission.
Patients were excluded from the study if they had docu-
mented structural heart disease, chronic renal failure, chronicliver cell failure, or advanced endocrine disorders (adrenal or
thyroid diseases, acromegaly, etc.).
All patients were subjected to thorough history taking
(whenever possible, or from their relatives), full clinical
examination, chest X-ray, abdominal ultrasound, urine analy-
sis, base line 12-lead electrocardiogram (ECG) with daily follow
up, transthoracic echocardiography, base line and continuous
arterial blood pressure (BP) and ventral venous pressure
(CVP) monitoring, full blood chemistry along with the other
routine laboratory tests, and cardiac troponin-I (cTnI) assay.
1.1.3. Statistical methods
Data were collected and coded prior to analysis using SPSS for
windows version 16. Continuous data are expressed as
mean ± one standard deviation (SD). Categorical data are pre-
sented as number of patients (percentage). Comparison of
means of two independent samples was done by Student’s t-test;
and comparison of proportions was done by Chi-square test. A
2-sided signiﬁcance level of 0.05 was used for all analyses.
1.1.4. Ethical approval
All patients gave informed consent to participate in this study.
2. Results
This study included 40 patients (24 males) aged 62.5 ±
9.1 years, who were diagnosed with various degrees of systemic
sepsis and were admitted to the CCU of Mansoura Medicine
Specialized Hospital and followed-up for one month. Table 1
shows the baseline clinical and other characteristics of these
patients on (or shortly after) CCU admission. All these pa-
tients were hypotensive on admission; but they were classiﬁed
into 2 groups as previously described in the methods section:
2.1. SIRS (survivor) group
Composed of 18 patients (13 males), aged 59.4 ± 8.7 years
with systemic inﬂammatory response and severe sepsis. These
patients had adequate response to ﬂuid resuscitation and 14
of them survived until hospital discharge.
2.2. Septic shock group
Composed of 22 patients (11 males), aged 65.1 ± 8.8 years
with septic shock. These patients did not respond to ﬂuid
resuscitation alone and were in need of vaso-active drug use.
A total of 18 patients in this group died in the CCU; 7 of them
(38.8%) died within 10 days of admission; while the rest (11
patients) died within 20 days.
Regarding the demographic and clinical data, patients in
both groups did not signiﬁcantly differ regarding the mean
age, gender distribution, or the prevalence of associatedmedical
and surgical conditions (hypertension, diabetes, malignancy,
and trauma); but signiﬁcant difference was found regarding
their hemodynamic indices on admission; that the patients with
septic shock exhibited signiﬁcantly higher mean HR and lower
systolic (SBP) and diastolic (DBP) blood pressures compared
to the patients with SIRS. Patients with SIRS had higher CVP
and RR than patients with septic shock; but the difference was
not statistically signiﬁcant. The source of infection was medical
Table 1 Baseline characteristic and comparisons between patients with sepsis (SIRS) and those with septic shock.
Variables Sepsis (n= 18) Septic shock (n= 22) p-Value
Demographic/clinical data
Age (years) 59.39 ± 8.6 65.3 ± 8.1 0.324
Male gender 13 (72.2%) 11 (50.0%) 0.27
Pulse (beat/min) 95.6 ± 6.3 106.6 ± 12.8 0.030*
Systolic blood pressure (mmHg) 114.7 ± 18.9 79.5 ± 5.3 0.005**
Diastolic blood pressure (mmHg) 69.4 ± 12.2 43.6 ± 7.2 0.001**
Central venous pressure (mmHg) 15.8 ± 3.9 9.6 ± 3.1 0.14
Respiratory rate (breath/min) 23.2 ± 4.3 22.8 ± 3.3 0.712
Source of infection
Medical 7 (38.9%) 8 (36.4%)
Surgical 11 (61.1%) 14 (63.6%) 0.868
Associated medical and surgical conditions
Hypertension 5 (27.8%) 10 (45.5%) 0.411
Diabetes 7 (38.9%) 11 (50.0%) 0.702
Malignancy 4 (22.2%) 8 (36.4%) 0.529
aTraum 3 (16.7%) 6 (27.3%) 0.676
Laboratory data
Total leukocytic count (·109/L) 16.1 ± 4.0 18.59 ± 4.2 0.115
Hemoglobin (gm/dL) 10.1 ± 1.6 9.4 ± 1.5 0.042*
Packed cell volume (%) 33.2 ± 3.5 31.3 ± 3.7 0.028*
Total bilirubin (mg/dL) 1.46 ± 0.47 1.63 ± 0.53 0.006**
AST (IU/L) 49.5 ± 14.0 56.2 ± 17.5 0.002**
ALT (IU/L) 52.0 ± 13.2 55.1 ± 17.0 0.030*
Blood urea nitrogen (mmol/L) 5.1 ± 2.0 6.3 ± 2.6 0.032*
Serum creatinine (mg/dL) 1.89 ± 0.79 2.55 ± 0.84 0.006**
MDRD eGFR (ml/min/1.73 m2) 51.6 ± 19.2 43.9 ± 18.5 0.04*
Cardiac troponin-I (ng/dL) 8.82 ± 0.81 11.98 ± 0.92 0.043*
Calcium (mg/dL) 8.85 ± 0.91 8.98 ± 1.05 0.075
C-reactive protein (mg/dL) 11.78 ± 4.9 14.73 ± 4.4 0.016*
Echocardiographic data
LV end-diastolic dimension (mm) 46.0 ± 2.7 53.0 ± 3.4 0.010*
LV end-systolic dimension (mm) 32.2 ± 3.0 39.7 ±.2.7 0.018*
LV Ejection fraction (%) 56.3 ± 11.6 45.6 ± 13.5 0.010*
IVRT (ms) 88.0 ± 8.1 74.5 ± 12.0 0.004**
E/A ratio 0.98 ± 0.15 1.32 ± 0.37 0.608
Deceleration time (ms) 210.2 ± 13.2 171.1 ± 15.4 0.033*
ALT: alanine transaminase; AST: aspartate transaminase; GFR: glomerular ﬁltration rate; IVRT: isovolumetric relaxation time; LV: left
ventricular; MDRD: modiﬁcation of diet in renal disease (formula).
* p< 0.05.
** p< 0.01.
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while it was surgical in the rest of patients (61% of SIRS and
64% of septic shock group respectively; p= 0.894).
In fact, the laboratory data of both groups showed consid-
erable differences as shown in Table 1; as the patients with sep-
tic shock had signiﬁcantly lower mean values for hemoglobin,
packed cell volume, and estimated glomerular ﬁltration rate;
and signiﬁcantly higher mean values for total bilirubin, liver
enzymes, blood urea nitrogen, serum creatinine, cTnI, and
C-reactive protein (CRP).
Indices of systolic function were signiﬁcantly impaired in
septic shock patients, as shown in Table 1, where signiﬁcantly
higher left ventricular systolic (LVESD) and diastolic
(LVEDD) dimensions and lower EF existed in these patients
compared with SIRS group. Similar to the systolic function,
the indices of diastolic function were also deranged in septic
shock patients; who had signiﬁcantly shorter mean isovolumet-
ric relaxation time (IVRT) and deceleration time (DT) thanSIRS patients; indicating the high prevalence of type 2
(pseudonormal) diastolic dysfunction in patients with septic
shock compared to the milder type 1 diastolic dysfunction
(impaired relaxation pattern) which predominated in SIRS
patients.
We further analyzed the non-survivor patients’ group, via
comparing the characteristics of the patients who died within
10 days and those who died within 20 days from admission.
As shown in Table 2, the variables which showed signiﬁcant
difference between both groups were the hemodynamic param-
eters on admission (SBP, DBP, and CVP) together with
LVESD and LVEDD. It is clear from the table that early mor-
tality was linked to lower SBD, DBP, and CVP on admission;
while late mortality was linked to lower LVEDD and LVESD.
Neither laboratory variables nor indices of diastolic function
differed signiﬁcantly between early and late mortalities in sep-
tic shock. However, only mean cTnI level was signiﬁcantly ele-
vated in the patients with early mortality.
Table 2 Comparative analysis of deaths which occurred within 10 days and within 20 days in patients with septic shock.
Variables Mortality within 10 days (n= 8) Mortality within 20 days (n= 14) p-Value
Demographic/clinical data
Age (years) 66.8 ± 5.3 64.1 ± 10.4 0.504
Male gender 4 (50.0%) 7 (50.0%) 1
Pulse (beat/min) 107.6 ± 12.6 105.1 ± 12.3 0.671
Systolic blood pressure (mmHg) 79.3 ± 10.3 111.7 ± 12.5 <0.001**
Diastolic blood pressure (mmHg) 47.6 ± 7.2 66.4 ± 10.1 <0.001**
Central venous pressure (mmHg) 9.6 ± 2.1 15.8 ± 3.9 <0.001**
Respiratory rate (breath/min) 23.4 ± 3.4 22.4 ± 3.3 0.532
Source of infection
Medical 3 (37.5%) 4 (28.6%) 0.894
Surgical 5 (62.5%) 10 (71.4%)
Associated medical and surgical conditions
Hypertension 4 (50.0%) 8 (57.1%) 0.843
Diabetes 6 (75.0%) 6 (42.9%) 0.407
Malignancy 1 (12.5%) 3 (21.4%) 0.875
Trauma 1 (12.5%) 2 (14.3%) 0.548
Laboratory data
Total leukocytic count (·109/L) 19.2 ± 4.5 17.3 ± 4.9 0.379
Hemoglobin (gm/dL) 9.7 ± 1.6 9.3 ± 1.5 0.885
Packed cell volume (%) 31.5 ± 3.0 31.2 ± 4.2 0.861
Total bilirubin (mg/dL) 1.68 ± 0.63 1.61 ± 0.49 0.774
AST (IU/L) 52.0 ± 11.3 58.1 ± 12.8 0.276
ALT (IU/L) 53.8 ± 13.2 55.1 ± 17.0 0.854
Blood urea nitrogen (mmol/L) 8.4 ± 2.7 7.2 ± 2.3 0.304
Serum creatinine (mg/dL) 2.74 ± 0.89 2.22 ± 0.68 0.169
MDRD eGFR (ml/min/1.73 m2) 44.1 ± 16.6 49.4 ± 19.0 0.501
Cardiac troponin-I (ng/dL) 13.01 ± 1.10 12.66 ± 0.98 0.449
Calcium (mg/dL) 8.9 ± 0.87 9.3 ± 1.08 0.353
C-reactive protein (mg/dL) 12.9 ± 3.7 14.2 ± 4.9 0.523
Echocardiographic data
LV end-diastolic dimension (mm) 54.5 ± 2.8 50.9 ± 3.2 0.012*
LV end-systolic dimension (mm) 40.6 ± 2.9 38.3 ± 1.9 0.035*
LV Ejection fraction (%) 45.5 ± 8.1 48.7 ± 10.2 0.758
IVRT (ms) 72.0 ± 12.6 82.3 ± 6.6 0.402
E/A ratio 1.39 ± 0.33 1.29 ± 0.24 0.242
Deceleration time (ms) 172.2 ± 17.5 170.1 ± 14.6 0.788
Abbreviations as in Table 1.
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independent variable against the positive outcome of mortality
within 10 days, the following were associated with mortality
within 10 days at p 6 0.1 (the entry threshold), and were thus
included in a ﬁnal stepwise logistic regression model: SBP,
DBP, CVP, LVESD, and LVEDD. Other important variables
were selected and put in the model despite their high p-entry
threshold (i.e. forced entry); these include: age, heart rate,
TLC, MDRD eGFR, hemoglobin level, CRP, cardiac tropo-
nin-I, and IVRT. We found that increment of LVEDD andTable 3 Results of ﬁnal multivariate logistic regression model used
positive outcome of mortality with 10 days in patients with septic sh
b-Coeﬃcient
LV end-diastolic dimension (mm) 0.077
Systolic blood pressure (mmHg) [5 units] 0.160
Cardiac troponin-I (ng/dL) [10 units] 1.345
OR, odds ratio; CI, conﬁdence interval.
Other abbreviations as in Table 1.troponin-I and decrement of SBP values were signiﬁcantly
and independently associated with mortality within 10 days
as shown in Table 3. The ﬁnal logistic regression model proved
to be highly signiﬁcant (p< 0.001), with good calibration
(Hosmer–Lemeshow Goodness-of-ﬁt v2 = 5.12, p= 0.715)
and high discriminative power (C-statistic = 0.87 [0.82–0.93];
p< 0.001, Nagelkerke R2 = 0.53). The model’s correlation
matrix was carefully checked to avoid collinearity, which was
excluded on the basis of reasonable correlations (generally,
r<±0.7).to test the independent association of the input variables with
ock.
OR 95%CI for OR p Value
1.085 1.017–1.159 0.018*
0.853 0.790–0.911 <0.001**
3.837 2.166–6.798 <0.001**
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Sepsis is the ﬁrst cause of death among critically ill patients
and accounts for more than 215,000 deaths every year in the
United States alone.2,9 Randomized controlled trials empha-
sizing early resuscitation have improved the prognosis of sepsis
by optimizing macro-circulatory parameters.4,10–12 Neverthe-
less, as many as 21–28% of patients with severe sepsis or septic
shock may die despite the aggressive resuscitation, normaliza-
tion of BP, and adequate global oxygen delivery; as septic
patients often exhibit persistent signs of tissue hypoperfusion
that ultimately lead to acidosis and multi-organ failure.2,3,7–12
Our results revealed signiﬁcant worsening of most labora-
tory parameters in septic shock patients compared to patients
with SIRS (Table 1), suggesting vital organ damage in the
shocked patients; which could be explained by the profound
hypoperfusion in patients with septic shock. Because septic
shock is deﬁned as the presence of SIRS criteria together with
hemodynamic instability, this may explain the signiﬁcantly
higher HR and lower SBP and DBP in septic shock patients
compared to SIRS group.
Out of the twenty-two patients with septic shock, 18
(81.2%) did not survive in this study; 7 of them died within
10 days of admission while the rest (11 patients) died within
20 days. These mortality rates are quite high when compared
with those reported by Shoemaker et al.13 (71.6%) and Vieil-
lard-Baron et al.14 (60%); a ﬁnding may be explained by the
more severe degree of septic shock encountered in our patients.
We found signiﬁcantly l EDD and ESD in septic shock pa-
tients compared to SIRS group, in line with some previous re-
ports.14,15 Besides, other investigators4,16 documented severe
LV dilatation in patient with septic shock. Furthermore, septic
shock mortalities within 20 days had signiﬁcantly increased
EDD and ESD in comparison with the mortalities within
10 days; conﬁrming the results of the previous studies.4,16
Signiﬁcantly lower EF mean value was found in shocked
patients compared to SIRS group (similar to the previous re-
ports4,14–16), a ﬁnding explained by the signiﬁcant myocardial
damage in septic shock patients was compared to the patients
with SIRS who had less affection of LV systolic function. In
fact, the signiﬁcant increase of troponin level in patients with
septic shock signiﬁes the damaging impact of this condition
on the myocardium.17,18 In general, a trend toward higher
mortality was documented in patients with increased myocar-
dial depressant activity compared to patients with low or ab-
sent activity.19 Court et al.16 assessed sera of patients with
septic shock, and discovered the generation of concentration-
dependant depressants of in vitro myocyte contractility. They
also demonstrated a strong correlation between the timing
and degree of septic shock-associated reduction of EF (in- vivo)
and cardiac myocyte depression (in vitro) after exposure to sera
from patients with septic shock. Hence, the presence of myo-
cardial depressant substances, which was conﬁrmed by Pathan
et al.20 would argue in favor of a circulating substance rather
than hypoperfusion as the causative factor of septic shock-
associated myocardial depression.
Septic shock patients in this study showed more prevalence
of type II (pseudo-normal) diastolic dysfunction compared
with type I (impaired relaxation) dysfunction which predomi-
nated in SIRS patients. The worsening diastolic dysfunction
in septic shock patients could be explained by the higherprevalence of fever and tachycardia in this group. These results
matched with Munt et al. who found lower values of DT and
E/A ratio in non-survivors versus survivors with septic shock,
and reported an association between the increased severity of
diastolic dysfunction and increased mortality in these pa-
tients.21 The high grade of diastolic dysfunction in septic shock
patients compared to SIRS ones may be explained as in the
case of systolic dysfunction. In fact, the grading of diastolic
dysfunction is very important in the prognosis of septic shock
patients, as marked diastolic dysfunction limits the adequate
volume resuscitation essential for recovery in shocked patients;
together with the early and inappropriate use of inotropic sup-
port in these relatively hypovolemic patients leading to more
tissue hypoperfusion and severe ischemia of vital organs.21,22
Signiﬁcant increase of CRP levels was noted in septic shock
patients compared to SIRS group in this study, in accordance
with the ﬁndings of Gabay et al.23 It is well known that acute
phase reactants reﬂect the presence and intensity of inﬂamma-
tion, and they have long been used as a clinical guide for diag-
nosis and management. In the present study, patients from
both groups had mean plasma CRP concentrations higher
than 10 mg/dl during one week observation period. However,
CRP plasma concentrations are increased in almost all postop-
erative patients regardless of the type of surgery24; and CRP is
not considered a valuable indicator of infection in medical
ICU due to its poor sensitivity and speciﬁcity.25
In conclusion, EDD and ESD are signiﬁcantly increased in
septic shock patients compared to patients with SIRS; while
EF shows the reverse. Patients with SIRS showed mild dia-
stolic dysfunction while severe form of diastolic dysfunction
has been found in patients with septic shock.
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